JMP Securities starts Astria Therapeutics stock at Market Outperform
JMP Securities initiated coverage on Astria Therapeutics (NASDAQ: ATXS), assigning a Market Outperform rating and setting a ...
JMP Securities raises Pharvaris stock target to $55
Wolleben's updated price target is a reflection of a revised revenue forecast for Pharvaris's prophylactic treatment, ...